BIOMEDICAL RESEARCH AND REVIEWS (ISSN:2631-3944)

Biography:

Dr. Lin has a distinguished career in analytical chemistry and biomedical research, currently serving as the Core Director of the Proteomics/Mass Spec Facility at the Center for Functional Genomics (CFG) since 2002. He also holds the position of Research Associate Professor in the Department of Biomedical Sciences at the School of Public Health, State University of New York at Albany.

Dr. Lin obtained his doctoral degree in Analytical Chemistry from the Institute of Chemistry, Chinese Academy of Sciences, China, in 1996. Following this, he advanced to the position of Research Associate Professor in 1997 to pursue his independent research interests in analytical chemistry. He furthered his training through a postdoctoral fellowship focusing on protein and membrane lipid biochemistry at the Howard Hughes Medical Institute, University of Washington, Seattle, under the mentorship of Dr. John Glomset, completing this in 2000.

Continuing his career trajectory, Dr. Lin pursued additional biomedical research fellowship training at the Heart Institute of Albany Medical Center, New York, in 2001, before taking on the role of chief proteomics/mass spec scientist at Myomatrix Therapeutics, LLC (Cytopia) in 2002. His expertise spans across proteomics, mass spectrometry, and biomedical sciences, where he has made significant contributions to advancing research in these fields through his leadership and scientific endeavors.

Research Interests:

His research interests include methodology development for proteomics, metabolomics, and mass spectrometry; mammalian cell membrane structure; phosphorylation in cellular signal transduction; and molecular proteomic changes in neurodegenerative and cardiovascular diseases.